First Time Loading...

Luye Pharma Group Ltd
HKEX:2186

Watchlist Manager
Luye Pharma Group Ltd Logo
Luye Pharma Group Ltd
HKEX:2186
Watchlist
Price: 3.02 HKD
Updated: May 6, 2024

Luye Pharma Group Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Luye Pharma Group Ltd
Net Income (Common) Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Luye Pharma Group Ltd
HKEX:2186
Net Income (Common)
¥532.6m
CAGR 3-Years
-9%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Net Income (Common)
¥3.3B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Net Income (Common)
¥2.8B
CAGR 3-Years
21%
CAGR 5-Years
22%
CAGR 10-Years
21%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Net Income (Common)
¥4.2B
CAGR 3-Years
-10%
CAGR 5-Years
2%
CAGR 10-Years
13%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Net Income (Common)
¥4.1B
CAGR 3-Years
-9%
CAGR 5-Years
3%
CAGR 10-Years
6%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Net Income (Common)
¥755.6m
CAGR 3-Years
36%
CAGR 5-Years
28%
CAGR 10-Years
N/A

See Also

What is Luye Pharma Group Ltd's Net Income (Common)?
Net Income (Common)
532.6m CNY

Based on the financial report for Dec 31, 2023, Luye Pharma Group Ltd's Net Income (Common) amounts to 532.6m CNY.

What is Luye Pharma Group Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-16%

Over the last year, the Net Income (Common) growth was -12%. The average annual Net Income (Common) growth rates for Luye Pharma Group Ltd have been -9% over the past three years , -16% over the past five years .